CMS is pursuing empiric fee-schedule accuracy in original Medicare (eg, validating procedure time assumptions) while rapidly expanding MSSP and CMMI pathways to move beyond unmanaged fee-for-service.
Eli Lilly LLY, a dominant player in the global obesity market, derives most of its revenues from its blockbuster GLP-1 medicines, Mounjaro for type II diabetes (T2D) and Zepbound for obesity. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results